Overview
Sweden-based health tech firm's Q4 net sales rose 0.9%, adjusted for currency effects
Operating profit for Q4 fell to SEK 8.3 mln due to increased headcount and initiatives
Company onboarded large customer in Norway, impacting Q4 margins
Outlook
Careium expects margin pressure to decrease from Q2 2026 onward
Impact of financial lease classifications in Sweden will reduce from Q1 2026
Careium aims to integrate operations and improve structural capital in 2026
Result Drivers
PRODUCT SALES - Product sales increased by 6.5% to SEK 67.1 mln, while service sales decreased by 1.3%
INITIATIVES IMPACT - Initiatives to integrate operations and modernize technology affected operating margins
NORWAY CUSTOMER - Onboarding a large customer in Norway resulted in upfront costs and margin pressure
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Sales
SEK 230.90 mln
Q4 Gross Margin
43.70%
Analyst Coverage
The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 10 three months ago
Press Release: ID:nMFN7hbcFv
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)